Cargando…
Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches
There are an estimated 6 million people with Down syndrome (DS) worldwide. In developed countries, the vast majority of these individuals will develop Alzheimer's disease neuropathology characterized by the accumulation of amyloid-β (Aβ) plaques and tau neurofibrillary tangles within the brain,...
Autores principales: | Farrell, Clíona, Mumford, Paige, Wiseman, Frances K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209729/ https://www.ncbi.nlm.nih.gov/pubmed/35747206 http://dx.doi.org/10.3389/fnins.2022.909669 |
Ejemplares similares
-
A Novel Ex Vivo Model to Investigate the Underlying Mechanisms in Alzheimer’s Disease
por: Brai, Emanuele, et al.
Publicado: (2017) -
Cell models for Down syndrome-Alzheimer’s disease research
por: Wu, Yixing, et al.
Publicado: (2022) -
Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease-Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin B
por: Wu, Yixing, et al.
Publicado: (2023) -
In vivo and ex vivo analyses of amyloid toxicity in the Tc1 mouse model of Down syndrome
por: Naert, Gaëlle, et al.
Publicado: (2017) -
Endosomal structure and APP biology are not altered in a preclinical mouse cellular model of Down syndrome
por: Cannavo, Claudia, et al.
Publicado: (2022)